Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298087497> ?p ?o ?g. }
- W4298087497 endingPage "3091" @default.
- W4298087497 startingPage "3078" @default.
- W4298087497 abstract "Objective This study explores LncRNA TM1‐3P effects on the proliferation, apoptosis, and inflammatory response of fibroblasts in osteoarthritis (OA) and its underlying mechanism. Methods Bioinformatics was performed to analyze OA disease‐related genes, miRNA profiles, and function. The targeted regulation of LncRNA TM1‐3P and miR‐144‐3p, ONECUT2 and miR‐144‐3p were analyzed by dual luciferase reporter gene assay, RNA Binding Protein Immunoprecipitation (RIP), and RNA pull down. Histopathological morphology of the knee joint was observed by hematoxylin–eosin (HE) and Annona Red O/Fast Green. The expressions of mRNAs and proteins were detected by RT‐qPCR, Western blot, and immunohistochemistry. Unpaired T test was used between groups, and the one‐way analysis of variance of repeated measurement data was applied for multi‐group comparison, following Tukey's post‐test. Results ONECUT2 and Smurf2 genes were significantly elevated in the osteoarthritis group compared with the normal group ( P < 0.001, P < 0.001). Expressions of ONECUT2 and LncRNA TM1‐3P were increased, and expression of miR‐144‐3p was decreased in interleukin (IL)‐1β‐induced human fibroblast synovial cells (hFSCs) (mRNA: 1.06 ± 0.24 vs. 3.29 ± 0.73, proteins: 0.22 ± 0.03 vs. 0.46 ± 0.22, 1.23 ± 0.22 vs. 3.76 ± 0.73, 1.06 ± 0.25 vs. 0.37 ± 0.13, P < 0.01, P < 0.001, P < 0.01, P < 0.05). Overexpression of miR‐144‐3p down‐regulated the ONECUT2 expression, reduced cell proliferation, promoted apoptosis in hFSCs induced by IL‐1β (mRNA: 0.89 ± 0.14 vs. 0.15 ± 0.01, P < 0.05; proteins: 0.46 ± 0.01 vs. 0.23 ± 0.01, P < 0.001; CCK8: 1.88 ± 0.07 vs. 1.65 ± 0.07; P < 0.05; EDU: 55.82 ± 1.44 vs 40.57 ± 2.24, P < 0.05; apoptosis: 10.57 ± 0.79 vs 16.36 ± 0.35, P < 0.0001). Overexpression of LncRNA TM1‐3P up‐regulated the expression of ONECUT2, promoted cell proliferation, and inhibited apoptosis (mRNA: 0.9 ± 0.09 vs 1.94 ± 0.12, P < 0.05; proteins: 0.61 ± 0.05 vs 0.76 ± 0.03, P > 0.05; CCK8: 2.07 ± 0.05 vs 2.47 ± 0.06; P < 0.01; EDU: 52.67 ± 1.17 vs 60.06 ± 3.24, P < 0.05; apoptosis: 10.57 ± 0.79 vs 16.36 ± 0.35, P < 0.001), which were reversed by the overexpression of miR‐144‐3p treatment (mRNA: 1.82 ± 0.07 vs 0.31 ± 0.07, P < 0.0001; proteins: 0.74 ± 0.02 vs 0.35 ± 0.01, P < 0.01; CCK8: 2.41 ± 0.01 vs 1.67 ± 0.02; P < 0.0001; EDU: 66.85 ± 2.86 vs 44.68 ± 1.97, P < 0.0001; apoptosis: 7.19 ± 0.19 vs 13.36 ± 0.53, P < 0.0001). Silencing LncRNA TM1‐3P attenuated the injury of knee joint tissue, down‐regulated the expression of ONECUT2, Smurf2, IL‐1β, IL‐6, TNF‐α, and improved the expression of Rap1 in rats (0.71 ± 0.04 vs 0.48 ± 0.02, 0.68 ± 0.06 vs 0.36 ± 0.02, 0.74 ± 0.03 vs 0.49 ± 0.04, 0.78 ± 0.01 vs 0.54 ± 0.03, 0.68 ± 0.02 vs 0.4 ± 0.04, 0.24 ± 0.01 vs 0.4 ± 0.03, P < 0.05, P < 0.05, P < 0.05, P < 0.01, P < 0.01, P < 0.05). Conclusion LncRNA TM1‐3P improved inflammation and damage of knee joints in OA rats through miR‐144‐3p/ONECUT2 axis, providing a new theoretical basis for gene therapy of OA." @default.
- W4298087497 created "2022-10-01" @default.
- W4298087497 creator A5015574141 @default.
- W4298087497 creator A5030104397 @default.
- W4298087497 creator A5064714920 @default.
- W4298087497 creator A5070072238 @default.
- W4298087497 creator A5089214053 @default.
- W4298087497 date "2022-09-30" @default.
- W4298087497 modified "2023-09-30" @default.
- W4298087497 title "<scp>LncRNA TM1‐3P</scp> Regulates Proliferation, Apoptosis and Inflammation of Fibroblasts in Osteoarthritis through <scp>miR</scp>‐144‐3p/<scp>ONECUT2</scp> Axis" @default.
- W4298087497 cites W2013865207 @default.
- W4298087497 cites W2262752392 @default.
- W4298087497 cites W2551062943 @default.
- W4298087497 cites W2605130562 @default.
- W4298087497 cites W2752120870 @default.
- W4298087497 cites W2761782867 @default.
- W4298087497 cites W2772861026 @default.
- W4298087497 cites W2891680741 @default.
- W4298087497 cites W2903046605 @default.
- W4298087497 cites W2903565890 @default.
- W4298087497 cites W2910991260 @default.
- W4298087497 cites W2939935027 @default.
- W4298087497 cites W2953709645 @default.
- W4298087497 cites W2955802364 @default.
- W4298087497 cites W2963268654 @default.
- W4298087497 cites W2963487203 @default.
- W4298087497 cites W2990772531 @default.
- W4298087497 cites W2997050693 @default.
- W4298087497 cites W3005637734 @default.
- W4298087497 cites W3010405431 @default.
- W4298087497 cites W3026385924 @default.
- W4298087497 cites W3026451748 @default.
- W4298087497 cites W3031468937 @default.
- W4298087497 cites W3042428745 @default.
- W4298087497 cites W3043124531 @default.
- W4298087497 cites W3044600719 @default.
- W4298087497 cites W3045131353 @default.
- W4298087497 cites W3083510557 @default.
- W4298087497 cites W3087792960 @default.
- W4298087497 cites W3091954724 @default.
- W4298087497 cites W3095078050 @default.
- W4298087497 cites W3103149491 @default.
- W4298087497 cites W3115260507 @default.
- W4298087497 cites W3118336577 @default.
- W4298087497 cites W3121857335 @default.
- W4298087497 cites W3128673975 @default.
- W4298087497 cites W3150199257 @default.
- W4298087497 cites W3155563774 @default.
- W4298087497 cites W3163623272 @default.
- W4298087497 cites W3164505233 @default.
- W4298087497 cites W3164632918 @default.
- W4298087497 cites W3178825706 @default.
- W4298087497 cites W3196895943 @default.
- W4298087497 cites W3207601909 @default.
- W4298087497 cites W3209665584 @default.
- W4298087497 cites W4213005002 @default.
- W4298087497 cites W4220982812 @default.
- W4298087497 cites W4281564849 @default.
- W4298087497 doi "https://doi.org/10.1111/os.13530" @default.
- W4298087497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36178080" @default.
- W4298087497 hasPublicationYear "2022" @default.
- W4298087497 type Work @default.
- W4298087497 citedByCount "2" @default.
- W4298087497 countsByYear W42980874972023 @default.
- W4298087497 crossrefType "journal-article" @default.
- W4298087497 hasAuthorship W4298087497A5015574141 @default.
- W4298087497 hasAuthorship W4298087497A5030104397 @default.
- W4298087497 hasAuthorship W4298087497A5064714920 @default.
- W4298087497 hasAuthorship W4298087497A5070072238 @default.
- W4298087497 hasAuthorship W4298087497A5089214053 @default.
- W4298087497 hasBestOaLocation W42980874971 @default.
- W4298087497 hasConcept C104317684 @default.
- W4298087497 hasConcept C105580179 @default.
- W4298087497 hasConcept C142724271 @default.
- W4298087497 hasConcept C145059251 @default.
- W4298087497 hasConcept C153911025 @default.
- W4298087497 hasConcept C16685009 @default.
- W4298087497 hasConcept C185592680 @default.
- W4298087497 hasConcept C190283241 @default.
- W4298087497 hasConcept C202751555 @default.
- W4298087497 hasConcept C203014093 @default.
- W4298087497 hasConcept C204232928 @default.
- W4298087497 hasConcept C204787440 @default.
- W4298087497 hasConcept C2776164576 @default.
- W4298087497 hasConcept C2776415932 @default.
- W4298087497 hasConcept C2776914184 @default.
- W4298087497 hasConcept C2780381497 @default.
- W4298087497 hasConcept C55493867 @default.
- W4298087497 hasConcept C62112901 @default.
- W4298087497 hasConcept C71924100 @default.
- W4298087497 hasConcept C86803240 @default.
- W4298087497 hasConceptScore W4298087497C104317684 @default.
- W4298087497 hasConceptScore W4298087497C105580179 @default.
- W4298087497 hasConceptScore W4298087497C142724271 @default.
- W4298087497 hasConceptScore W4298087497C145059251 @default.
- W4298087497 hasConceptScore W4298087497C153911025 @default.
- W4298087497 hasConceptScore W4298087497C16685009 @default.
- W4298087497 hasConceptScore W4298087497C185592680 @default.